VINC(Delisted)
Vincerx Pharma·NASDAQ
--
--(--)
VINC Filings
Filing Date
Form Description
Form Type
2025-07-29
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-07-29 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-07-16
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Key Events
2025-07-16 · Key Events
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
2025-07-07
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Key Events
2025-07-07 · Key Events
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
2025-07-07
Form 8-K - Current report
Key Events
2025-07-07 · Key Events
Form 8-K - Current report
2025-06-18
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Key Events
2025-06-18 · Key Events
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
2025-06-06
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Key Events
2025-06-06 · Key Events
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
2025-05-15
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-05-15 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-05-15
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-05-15 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-05-12
Form DEF 14A - Other definitive proxy statements
Key Events
2025-05-12 · Key Events
Form DEF 14A - Other definitive proxy statements
2025-05-05
Form EFFECT - Notice of Effectiveness
2025-05-05 ·
Form EFFECT - Notice of Effectiveness
